Nonsteroidal anti-inflammatory drugs, especially aspirin, are linked to lower risk and better survival of hepatocellular carcinoma: a meta-analysis

References

• HeimbachJKKulikLMFinnRSAASLD guidelines for the treatment of hepatocellular carcinomaHepatology201867135838028130846
   PubMed Web of Science ®Google Scholar
• OmataMChengALKokudoNAsia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 updateHepatol Int201711431737028620797
   PubMed Web of Science ®Google Scholar
• SiegelRLMillerKDJemalACancer statistics, 2017CA Cancer J Clin201767173028055103
   PubMed Web of Science ®Google Scholar
• LozanoRNaghaviMForemanKGlobal and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010Lancet201238098592095212823245604
   PubMed Web of Science ®Google Scholar
• PetrickJLKellySPAltekruseSFMcGlynnKARosenbergPSFuture of hepatocellular carcinoma incidence in the United States forecast through 2030J Clin Oncol201634151787179427044939
   PubMed Web of Science ®Google Scholar
• MillerKDSiegelRLLinCCCancer treatment and survivorship statistics, 2016CA Cancer J Clin201666427128927253694
   PubMed Web of Science ®Google Scholar
• KimAKDziuraJStrazzaboscoMNonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma: the egg of columbus or another illusion?Hepatology201358281982123703812
   PubMed Web of Science ®Google Scholar
• HossainMAKimDHJangJYAspirin enhances doxorubicin-induced apoptosis and reduces tumor growth in human hepatocellular carcinoma cells in vitro and in vivoInt J Oncol20124051636164222322725
   PubMed Web of Science ®Google Scholar
• FajardoAMPiazzaGAChemoprevention in gastrointestinal physiology and disease. Anti-inflammatory approaches for colorectal cancer chemopreventionAm J Physiol Gastrointest Liver Physiol20153092G59G7026021807
   PubMed Web of Science ®Google Scholar
• HuaXPhippsAIBurnett-HartmanANTiming of aspirin and other nonsteroidal anti-inflammatory drug use among patients with colorectal cancer in relation to tumor markers and survivalJ Clin Oncol201735242806281328617623
   PubMed Web of Science ®Google Scholar
• van StaalduinenJFrouwsMReimersMThe effect of aspirin and nonsteroidal anti-inflammatory drug use after diagnosis on survival of oesophageal cancer patientsBr J Cancer201611491053105927115570
   PubMed Web of Science ®Google Scholar
• PatelDKitaharaCMParkYThyroid cancer and nonsteroidal anti-inflammatory drug use: a pooled analysis of patients older than 40 years of ageThyroid201525121355136226426828
   PubMed Web of Science ®Google Scholar
• SkriverCDehlendorffCBorreMLow-dose aspirin or other nonsteroidal anti-inflammatory drug use and prostate cancer risk: a nationwide studyCancer Causes Control20162791067107927503490
   PubMed Web of Science ®Google Scholar
• LadAAMaYLeeJANo association between nonsteroidal anti-inflammatory drug use and pancreatic cancer incidence and survivalPancreas2017465e43e4528426499
   PubMed Web of Science ®Google Scholar
• SitiaGAiolfiRDi LuciaPMainettiMFiocchiAMingozziFAntiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis BProc Natl Acad Sci USA201210932E2165E217222753481
   PubMed Web of Science ®Google Scholar
• SahasrabuddheVVGunjaMZGraubardBINonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinomaJ Natl Cancer Inst2012104231808181423197492
   PubMedGoogle Scholar
• ZengXZhangYKwongJSThe methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic reviewJ Evid Based Med20158121025594108
   PubMedGoogle Scholar
• WellsGASheaBO’ConnellDThe Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.aspAccessed August 1, 2018
   Google Scholar
• ZhangJYuKFWhat’s the relative risk? A method of correcting the odds ratio in cohort studies of common outcomesJAMA199828019169016919832001
   PubMed Web of Science ®Google Scholar
• HigginsJPThompsonSGQuantifying heterogeneity in a meta-analysisStat Med200221111539155812111919
   PubMed Web of Science ®Google Scholar
• EggerMDavey SmithGSchneiderMMinderCBias in meta-analysis detected by a simple, graphical testBMJ199731571096296349310563
   PubMed Web of Science ®Google Scholar
• LeePCYehCMHuYWAntiplatelet therapy is associated with a better prognosis for patients with hepatitis B virus-related hepatocellular carcinoma after liver resectionAnn Surg Oncol201623Suppl 587488327541812
   PubMedGoogle Scholar
• CooganPFRosenbergLPalmerJRNonsteroidal anti-inflammatory drugs and risk of digestive cancers at sites other than the large bowelCancer Epidemiol Biomarkers Prev20009111912310667472
   PubMed Web of Science ®Google Scholar
• LeeMChungGELeeJHAntiplatelet therapy and the risk of hepatocellular carcinoma in chronic hepatitis B patients on antiviral treatmentHepatology20176651556156928617992
   PubMed Web of Science ®Google Scholar
• OhSShinSLeeSHAspirin and the risk of hepatocellular carcinoma development in patients with compensated alcoholic cirrhosisJ Hepatol2017661S629S630
   Web of Science ®Google Scholar
• PetrickJLSahasrabuddheVVChanATNSAID use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: the liver cancer pooling projectCancer Prev Res (Phila)20158121156116226391917
   PubMed Web of Science ®Google Scholar
• YangBPetrickJLChenJAssociations of NSAID and paracetamol use with risk of primary liver cancer in the Clinical Practice Research DatalinkCancer Epidemiol20164310511127420633
   PubMed Web of Science ®Google Scholar
• LiJHWangYXieXYAspirin in combination with TACE in treatment of unresectable HCC: a matched-pairs analysisAm J Cancer Res2016692109211627725915
   PubMed Web of Science ®Google Scholar
• TakamiYEguchiSTateishiMA randomised controlled trial of meloxicam, a Cox-2 inhibitor, to prevent hepatocellular carcinoma recurrence after initial curative treatmentHepatol Int201610579980626846471
   PubMed Web of Science ®Google Scholar
• WuCYChenYJHoHJAssociation between nucleoside analogues and risk of hepatitis B virus-related hepatocellular carcinoma recurrence following liver resectionJAMA2012308181906191423162861
   PubMed Web of Science ®Google Scholar
• YehCCLinJTJengLBNonsteroidal anti-inflammatory drugs are associated with reduced risk of early hepatocellular carcinoma recurrence after curative liver resection: a nationwide cohort studyAnn Surg2015261352152624950265
   PubMed Web of Science ®Google Scholar
• BerasainCCastilloJPerugorriaMJLatasaMUPrietoJAvilaMAInflammation and liver cancer: new molecular linksAnn N Y Acad Sci2009115520622119250206
   PubMed Web of Science ®Google Scholar
• AravalliRNSteerCJCressmanENMolecular mechanisms of hepatocellular carcinomaHepatology20084862047206319003900
   PubMed Web of Science ®Google Scholar
• RobertsLRGoresGJHepatocellular carcinoma: molecular pathways and new therapeutic targetsSemin Liver Dis200525221222515918149
   PubMed Web of Science ®Google Scholar
• CoussensLMWerbZInflammation and cancerNature2002420691786086712490959
   PubMed Web of Science ®Google Scholar
• CoffeltSBde VisserKECancer: inflammation lights the way to metastasisNature20145077490484924572360
   PubMed Web of Science ®Google Scholar
• SarvaiyaPJGuoDUlasovIGabikianPLesniakMSChemokines in tumor progression and metastasisOncotarget20134122171218524259307
   PubMed Web of Science ®Google Scholar
• LengJHanCDemetrisAJMichalopoulosGKWuTCyclooxygenase-2 promotes hepatocellular carcinoma cell growth through Akt activation: evidence for Akt inhibition in celecoxib-induced apoptosisHepatology200338375676812939602
   PubMed Web of Science ®Google Scholar
• FoderaDD’AlessandroNCusimanoAInduction of apoptosis and inhibition of cell growth in human hepatocellular carcinoma cells by COX-2 inhibitorsAnn N Y Acad Sci2004102844044915650269
   PubMed Web of Science ®Google Scholar
• FredrikssonLHerpersBBenedettiGDiclofenac inhibits tumor necrosis factor-alpha-induced nuclear factor-kappaB activation causing synergistic hepatocyte apoptosisHepatology20115362027204121433042
   PubMed Web of Science ®Google Scholar
• AbiruSNakaoKIchikawaTAspirin and NS-398 inhibit hepatocyte growth factor-induced invasiveness of human hepatoma cellsHepatology20023551117112411981761
   PubMed Web of Science ®Google Scholar
• SahinIHHassanMMGarrettCRImpact of non-steroidal anti-inflammatory drugs on gastrointestinal cancers: current state-of-the scienceCancer Lett2014345224925724021750
   PubMed Web of Science ®Google Scholar
• KogaHSakisakaSOhishiMExpression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiationHepatology199929368869610051469
   PubMed Web of Science ®Google Scholar
• ShiotaGOkuboMNoumiTCyclooxygenase-2 expression in hepatocellular carcinomaHepatogastroenterology1999462540741210228831
   PubMedGoogle Scholar
• HwangSJLuoJCLiCPThrombocytosis: a paraneoplastic syndrome in patients with hepatocellular carcinomaWorld J Gastroenterol200410172472247715300887
   PubMed Web of Science ®Google Scholar
• StoneRLNickAMMcNeishIAParaneoplastic thrombocytosis in ovarian cancerN Engl J Med2012366761061822335738
   PubMed Web of Science ®Google Scholar
• SimanekRVormittagRAyCHigh platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)J Thromb Haemost20108111412019889150
   PubMed Web of Science ®Google Scholar
• GayLJFelding-HabermannBContribution of platelets to tumour metastasisNat Rev Cancer201111212313421258396
   PubMed Web of Science ®Google Scholar
• Ho-Tin-NoeBGoergeTWagnerDDPlatelets: guardians of tumor vasculatureCancer Res200969145623562619584268
   PubMed Web of Science ®Google Scholar
• ThunMJJacobsEJPatronoCThe role of aspirin in cancer preventionNat Rev Clin Oncol20129525926722473097
   PubMed Web of Science ®Google Scholar
• KondoRYanoHNakashimaOTanikawaKNomuraYKageMAccumulation of platelets in the liver may be an important contributory factor to thrombocytopenia and liver fibrosis in chronic hepatitis CJ Gastroenterol201348452653422911171
   PubMed Web of Science ®Google Scholar
• StarlingerPAssingerAHaegeleSEvidence for serotonin as a relevant inducer of liver regeneration after liver resection in humansHepatology201460125726624277679
   PubMed Web of Science ®Google Scholar
• WalshTGMetharomPBerndtMCThe functional role of platelets in the regulation of angiogenesisPlatelets201526319921124832135
   PubMed Web of Science ®Google Scholar
• DineenSPRolandCLToombsJEThe acellular fraction of stored platelets promotes tumor cell invasionJ Surg Res2009153113213718541268
   PubMed Web of Science ®Google Scholar
• LabelleMBegumSHynesRODirect signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasisCancer Cell201120557659022094253
   PubMed Web of Science ®Google Scholar
• XueTCGeNLXuXLeFZhangBHWangYHHigh platelet counts increase metastatic risk in huge hepatocellular carcinoma undergoing transarterial chemoembolizationHepatol Res201646101028103626776560
   PubMed Web of Science ®Google Scholar
• LeeCHLinYJLinCCPretreatment platelet count early predicts extra-hepatic metastasis of human hepatomaLiver Int201535102327233625752212
   PubMed Web of Science ®Google Scholar
• PangQZhangJYXuXSSignificance of platelet count and platelet-based models for hepatocellular carcinoma recurrenceWorld J Gastroenterol201521185607562125987786
   PubMed Web of Science ®Google Scholar
• BuergyDWenzFGrodenCBrockmannMATumor-platelet interaction in solid tumorsInt J Cancer2012130122747276022261860
   PubMed Web of Science ®Google Scholar
• NousoKItoYKuwakiKPrognostic factors and treatment effects for hepatocellular carcinoma in Child C cirrhosisBr J Cancer20089871161116518349849
   PubMed Web of Science ®Google Scholar
• CervelloMMontaltoGCyclooxygenases in hepatocellular carcinomaWorld J Gastroenterol200612325113512116937518
   PubMed Web of Science ®Google Scholar